Tumor-suppressing multi-enterobacteria enhance the anti-PD-1/PD-L1 efficacy in microsatellite stable colorectal cancer.
0/5 보강
APA
Su X, Jin J, et al. (2026). Tumor-suppressing multi-enterobacteria enhance the anti-PD-1/PD-L1 efficacy in microsatellite stable colorectal cancer.. Scientific reports. https://doi.org/10.1038/s41598-026-44494-5
MLA
Su X, et al.. "Tumor-suppressing multi-enterobacteria enhance the anti-PD-1/PD-L1 efficacy in microsatellite stable colorectal cancer.." Scientific reports, 2026.
PMID
41851187
같은 제1저자의 인용 많은 논문 (5)
- Metabolic signatures and predictive biomarkers of liposomal doxorubicin-induced hypersensitivity in breast cancer: A pilot study.
- Suppression Probe Enrichment for Highly Sensitive and Multiplexed Detection of RAS Mutations in Colorectal Cancer.
- Research progress on the application of traditional Chinese medicine in regulating NF-κB signaling pathway for the treatment of ovarian cancer.
- Chromatin-binding protein HMGN1 promotes HCC tumorigenesis via histone methylation-induced RALB transcriptional suppression.
- Targeted delivery and controlled release of deferasirox for melanoma therapy.